Industry Research Reports

Home > Reports > Medical Devices & Consumables > Ultra-large Volume Wearable Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Ultra-large Volume Wearable Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-24

Pages: 127 Pages

Report ld: 2333870

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Ultra-large volume wearable injectors are a new innovation within the injectable drug delivery market. These injectors are used to deliver large (>1-2 mL) volumes of drugs to drug developers, clinicians, and patients.

The global market for Ultra-large Volume Wearable Injectors was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Ultra-large Volume Wearable Injectors include Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Ultra-large Volume Wearable Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ultra-large Volume Wearable Injectors by region & country, by Type, and by Application.

The Ultra-large Volume Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ultra-large Volume Wearable Injectors.

Market Segmentation

Report Metric
Details
Report Title
Ultra-large Volume Wearable Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Ultra-large Volume Wearable Injectors Companies Covered
Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections, Sorrel Medical, E3D Elcam Drug Delivery Devices
Global Ultra-large Volume Wearable Injectors Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ultra-large Volume Wearable Injectors Market, Segment by Type
On-Body Injectors

Off-Body Injectors
Global Ultra-large Volume Wearable Injectors Market, Segment by Application
Hospitals

Clinics

Home Care Settings

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ultra-large Volume Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ultra-large Volume Wearable Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ultra-large Volume Wearable Injectors in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Ultra-large Volume Wearable Injectors Product Introduction
    1.2 Global Ultra-large Volume Wearable Injectors Market Size Forecast
        1.2.1 Global Ultra-large Volume Wearable Injectors Sales Value (2019-2030)
        1.2.2 Global Ultra-large Volume Wearable Injectors Sales Volume (2019-2030)
        1.2.3 Global Ultra-large Volume Wearable Injectors Sales Price (2019-2030)
    1.3 Ultra-large Volume Wearable Injectors Market Trends & Drivers
        1.3.1 Ultra-large Volume Wearable Injectors Industry Trends
        1.3.2 Ultra-large Volume Wearable Injectors Market Drivers & Opportunity
        1.3.3 Ultra-large Volume Wearable Injectors Market Challenges
        1.3.4 Ultra-large Volume Wearable Injectors Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Ultra-large Volume Wearable Injectors Players Revenue Ranking (2023)
    2.2 Global Ultra-large Volume Wearable Injectors Revenue by Company (2019-2024)
    2.3 Global Ultra-large Volume Wearable Injectors Players Sales Volume Ranking (2023)
    2.4 Global Ultra-large Volume Wearable Injectors Sales Volume by Company Players (2019-2024)
    2.5 Global Ultra-large Volume Wearable Injectors Average Price by Company (2019-2024)
    2.6 Key Manufacturers Ultra-large Volume Wearable Injectors Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Ultra-large Volume Wearable Injectors Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Ultra-large Volume Wearable Injectors
    2.9 Ultra-large Volume Wearable Injectors Market Competitive Analysis
        2.9.1 Ultra-large Volume Wearable Injectors Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Ultra-large Volume Wearable Injectors Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra-large Volume Wearable Injectors as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 On-Body Injectors
        3.1.2 Off-Body Injectors
    3.2 Global Ultra-large Volume Wearable Injectors Sales Value by Type
        3.2.1 Global Ultra-large Volume Wearable Injectors Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Ultra-large Volume Wearable Injectors Sales Value, by Type (2019-2030)
        3.2.3 Global Ultra-large Volume Wearable Injectors Sales Value, by Type (%) (2019-2030)
    3.3 Global Ultra-large Volume Wearable Injectors Sales Volume by Type
        3.3.1 Global Ultra-large Volume Wearable Injectors Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Ultra-large Volume Wearable Injectors Sales Volume, by Type (2019-2030)
        3.3.3 Global Ultra-large Volume Wearable Injectors Sales Volume, by Type (%) (2019-2030)
    3.4 Global Ultra-large Volume Wearable Injectors Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Home Care Settings
        4.1.4 Others
    4.2 Global Ultra-large Volume Wearable Injectors Sales Value by Application
        4.2.1 Global Ultra-large Volume Wearable Injectors Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Ultra-large Volume Wearable Injectors Sales Value, by Application (2019-2030)
        4.2.3 Global Ultra-large Volume Wearable Injectors Sales Value, by Application (%) (2019-2030)
    4.3 Global Ultra-large Volume Wearable Injectors Sales Volume by Application
        4.3.1 Global Ultra-large Volume Wearable Injectors Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Ultra-large Volume Wearable Injectors Sales Volume, by Application (2019-2030)
        4.3.3 Global Ultra-large Volume Wearable Injectors Sales Volume, by Application (%) (2019-2030)
    4.4 Global Ultra-large Volume Wearable Injectors Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Ultra-large Volume Wearable Injectors Sales Value by Region
        5.1.1 Global Ultra-large Volume Wearable Injectors Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Ultra-large Volume Wearable Injectors Sales Value by Region (2019-2024)
        5.1.3 Global Ultra-large Volume Wearable Injectors Sales Value by Region (2025-2030)
        5.1.4 Global Ultra-large Volume Wearable Injectors Sales Value by Region (%), (2019-2030)
    5.2 Global Ultra-large Volume Wearable Injectors Sales Volume by Region
        5.2.1 Global Ultra-large Volume Wearable Injectors Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2019-2024)
        5.2.3 Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2025-2030)
        5.2.4 Global Ultra-large Volume Wearable Injectors Sales Volume by Region (%), (2019-2030)
    5.3 Global Ultra-large Volume Wearable Injectors Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        5.4.2 North America Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        5.5.2 Europe Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        5.6.2 Asia Pacific Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        5.7.2 South America Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        5.8.2 Middle East & Africa Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value
        6.2.1 Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.3.2 United States Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.4.2 Europe Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.5.2 China Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.6.2 Japan Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.7.2 South Korea Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.8.2 Southeast Asia Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Ultra-large Volume Wearable Injectors Sales Value, 2019-2030
        6.9.2 India Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Ultra-large Volume Wearable Injectors Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Ypsomed
        7.1.1 Ypsomed Company Information
        7.1.2 Ypsomed Introduction and Business Overview
        7.1.3 Ypsomed Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Ypsomed Ultra-large Volume Wearable Injectors Product Offerings
        7.1.5 Ypsomed Recent Development
    7.2 Amgen
        7.2.1 Amgen Company Information
        7.2.2 Amgen Introduction and Business Overview
        7.2.3 Amgen Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Amgen Ultra-large Volume Wearable Injectors Product Offerings
        7.2.5 Amgen Recent Development
    7.3 West Pharmaceuticals
        7.3.1 West Pharmaceuticals Company Information
        7.3.2 West Pharmaceuticals Introduction and Business Overview
        7.3.3 West Pharmaceuticals Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 West Pharmaceuticals Ultra-large Volume Wearable Injectors Product Offerings
        7.3.5 West Pharmaceuticals Recent Development
    7.4 Unilife Corporation
        7.4.1 Unilife Corporation Company Information
        7.4.2 Unilife Corporation Introduction and Business Overview
        7.4.3 Unilife Corporation Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Unilife Corporation Ultra-large Volume Wearable Injectors Product Offerings
        7.4.5 Unilife Corporation Recent Development
    7.5 CeQur
        7.5.1 CeQur Company Information
        7.5.2 CeQur Introduction and Business Overview
        7.5.3 CeQur Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 CeQur Ultra-large Volume Wearable Injectors Product Offerings
        7.5.5 CeQur Recent Development
    7.6 Sensile Medical
        7.6.1 Sensile Medical Company Information
        7.6.2 Sensile Medical Introduction and Business Overview
        7.6.3 Sensile Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Sensile Medical Ultra-large Volume Wearable Injectors Product Offerings
        7.6.5 Sensile Medical Recent Development
    7.7 BD Medical
        7.7.1 BD Medical Company Information
        7.7.2 BD Medical Introduction and Business Overview
        7.7.3 BD Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 BD Medical Ultra-large Volume Wearable Injectors Product Offerings
        7.7.5 BD Medical Recent Development
    7.8 Enable Injections
        7.8.1 Enable Injections Company Information
        7.8.2 Enable Injections Introduction and Business Overview
        7.8.3 Enable Injections Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Enable Injections Ultra-large Volume Wearable Injectors Product Offerings
        7.8.5 Enable Injections Recent Development
    7.9 Sorrel Medical
        7.9.1 Sorrel Medical Company Information
        7.9.2 Sorrel Medical Introduction and Business Overview
        7.9.3 Sorrel Medical Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Sorrel Medical Ultra-large Volume Wearable Injectors Product Offerings
        7.9.5 Sorrel Medical Recent Development
    7.10 E3D Elcam Drug Delivery Devices
        7.10.1 E3D Elcam Drug Delivery Devices Company Information
        7.10.2 E3D Elcam Drug Delivery Devices Introduction and Business Overview
        7.10.3 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Product Offerings
        7.10.5 E3D Elcam Drug Delivery Devices Recent Development

 8 Industry Chain Analysis
    8.1 Ultra-large Volume Wearable Injectors Industrial Chain
    8.2 Ultra-large Volume Wearable Injectors Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Ultra-large Volume Wearable Injectors Sales Model
        8.5.2 Sales Channel
        8.5.3 Ultra-large Volume Wearable Injectors Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Ultra-large Volume Wearable Injectors Market Trends
    Table 2. Ultra-large Volume Wearable Injectors Market Drivers & Opportunity
    Table 3. Ultra-large Volume Wearable Injectors Market Challenges
    Table 4. Ultra-large Volume Wearable Injectors Market Restraints
    Table 5. Global Ultra-large Volume Wearable Injectors Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Ultra-large Volume Wearable Injectors Revenue Market Share by Company (2019-2024)
    Table 7. Global Ultra-large Volume Wearable Injectors Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Ultra-large Volume Wearable Injectors Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Ultra-large Volume Wearable Injectors Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Ultra-large Volume Wearable Injectors Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Ultra-large Volume Wearable Injectors Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Ultra-large Volume Wearable Injectors
    Table 13. Global Ultra-large Volume Wearable Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra-large Volume Wearable Injectors as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ultra-large Volume Wearable Injectors Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Ultra-large Volume Wearable Injectors Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Ultra-large Volume Wearable Injectors Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Ultra-large Volume Wearable Injectors Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Ultra-large Volume Wearable Injectors Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Ultra-large Volume Wearable Injectors Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Ultra-large Volume Wearable Injectors Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Ultra-large Volume Wearable Injectors Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Ultra-large Volume Wearable Injectors Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Ultra-large Volume Wearable Injectors Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Ultra-large Volume Wearable Injectors Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Ultra-large Volume Wearable Injectors Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Ultra-large Volume Wearable Injectors Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Ultra-large Volume Wearable Injectors Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Ultra-large Volume Wearable Injectors Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Ultra-large Volume Wearable Injectors Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Ultra-large Volume Wearable Injectors Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Ultra-large Volume Wearable Injectors Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Ultra-large Volume Wearable Injectors Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Ultra-large Volume Wearable Injectors Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Ultra-large Volume Wearable Injectors Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Ultra-large Volume Wearable Injectors Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Ultra-large Volume Wearable Injectors Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Ultra-large Volume Wearable Injectors Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Ultra-large Volume Wearable Injectors Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Ultra-large Volume Wearable Injectors Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Ultra-large Volume Wearable Injectors Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Ultra-large Volume Wearable Injectors Sales Value by Region (2019-2024) & (%)
    Table 44. Global Ultra-large Volume Wearable Injectors Sales Value by Region (2025-2030) & (%)
    Table 45. Global Ultra-large Volume Wearable Injectors Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Ultra-large Volume Wearable Injectors Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Ultra-large Volume Wearable Injectors Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Ultra-large Volume Wearable Injectors Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Volume, (2025-2030) & (K Units)
    Table 57. Ypsomed Company Information
    Table 58. Ypsomed Introduction and Business Overview
    Table 59. Ypsomed Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Ypsomed Ultra-large Volume Wearable Injectors Product Offerings
    Table 61. Ypsomed Recent Development
    Table 62. Amgen Company Information
    Table 63. Amgen Introduction and Business Overview
    Table 64. Amgen Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Amgen Ultra-large Volume Wearable Injectors Product Offerings
    Table 66. Amgen Recent Development
    Table 67. West Pharmaceuticals Company Information
    Table 68. West Pharmaceuticals Introduction and Business Overview
    Table 69. West Pharmaceuticals Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. West Pharmaceuticals Ultra-large Volume Wearable Injectors Product Offerings
    Table 71. West Pharmaceuticals Recent Development
    Table 72. Unilife Corporation Company Information
    Table 73. Unilife Corporation Introduction and Business Overview
    Table 74. Unilife Corporation Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Unilife Corporation Ultra-large Volume Wearable Injectors Product Offerings
    Table 76. Unilife Corporation Recent Development
    Table 77. CeQur Company Information
    Table 78. CeQur Introduction and Business Overview
    Table 79. CeQur Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. CeQur Ultra-large Volume Wearable Injectors Product Offerings
    Table 81. CeQur Recent Development
    Table 82. Sensile Medical Company Information
    Table 83. Sensile Medical Introduction and Business Overview
    Table 84. Sensile Medical Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Sensile Medical Ultra-large Volume Wearable Injectors Product Offerings
    Table 86. Sensile Medical Recent Development
    Table 87. BD Medical Company Information
    Table 88. BD Medical Introduction and Business Overview
    Table 89. BD Medical Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. BD Medical Ultra-large Volume Wearable Injectors Product Offerings
    Table 91. BD Medical Recent Development
    Table 92. Enable Injections Company Information
    Table 93. Enable Injections Introduction and Business Overview
    Table 94. Enable Injections Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Enable Injections Ultra-large Volume Wearable Injectors Product Offerings
    Table 96. Enable Injections Recent Development
    Table 97. Sorrel Medical Company Information
    Table 98. Sorrel Medical Introduction and Business Overview
    Table 99. Sorrel Medical Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Sorrel Medical Ultra-large Volume Wearable Injectors Product Offerings
    Table 101. Sorrel Medical Recent Development
    Table 102. E3D Elcam Drug Delivery Devices Company Information
    Table 103. E3D Elcam Drug Delivery Devices Introduction and Business Overview
    Table 104. E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Product Offerings
    Table 106. E3D Elcam Drug Delivery Devices Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Ultra-large Volume Wearable Injectors Downstream Customers
    Table 110. Ultra-large Volume Wearable Injectors Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ultra-large Volume Wearable Injectors Product Picture
    Figure 2. Global Ultra-large Volume Wearable Injectors Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Ultra-large Volume Wearable Injectors Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Ultra-large Volume Wearable Injectors Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Ultra-large Volume Wearable Injectors Report Years Considered
    Figure 7. Global Ultra-large Volume Wearable Injectors Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Ultra-large Volume Wearable Injectors Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ultra-large Volume Wearable Injectors Revenue in 2023
    Figure 10. Ultra-large Volume Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. On-Body Injectors Picture
    Figure 12. Off-Body Injectors Picture
    Figure 13. Global Ultra-large Volume Wearable Injectors Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Ultra-large Volume Wearable Injectors Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Ultra-large Volume Wearable Injectors Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Ultra-large Volume Wearable Injectors Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Ultra-large Volume Wearable Injectors Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Home Care Settings
    Figure 21. Product Picture of Others
    Figure 22. Global Ultra-large Volume Wearable Injectors Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Ultra-large Volume Wearable Injectors Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Ultra-large Volume Wearable Injectors Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Ultra-large Volume Wearable Injectors Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Ultra-large Volume Wearable Injectors Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Ultra-large Volume Wearable Injectors Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Ultra-large Volume Wearable Injectors Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Ultra-large Volume Wearable Injectors Sales Volume (%), (2019-2030)
    Figure 39. United States Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Ultra-large Volume Wearable Injectors Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Ultra-large Volume Wearable Injectors Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Ultra-large Volume Wearable Injectors Sales Value by Application (%), 2023 VS 2030
    Figure 60. Ultra-large Volume Wearable Injectors Industrial Chain
    Figure 61. Ultra-large Volume Wearable Injectors Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

Ultra-large volume wearable injectors are a new innovation within the injectable drug delivery market. These injectors are used to deliver large (>1-2 mL) volumes of drugs to drug developers, clinicians, and patients.

The global market for Ultra-large Volume Wearable Injectors was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Ultra-large Volume Wearable Injectors was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Ultra-large Volume Wearable Injectors include Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Ultra-large Volume Wearable Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ultra-large Volume Wearable Injectors by region & country, by Type, and by Application.

The Ultra-large Volume Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ultra-large Volume Wearable Injectors.

Market Segmentation